NLRP3 and colorectal carcinoma: Immunohistochemistry and microarray analysis of the NLRP3 pathway have shown it to be up-regulated in patients affected by CRC, with significantly higher levels of ASC, Caspase-1 and IL-1β than in control tissues [119].